Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-49,833
Closed -$21K 3382
2024
Q2
$21K Buy
+49,833
New +$18.1K ﹤0.01% 1929
2022
Q3
Sell
-85,721
Closed -$847K 3685
2022
Q2
$847K Buy
85,721
+700
+0.8% +$6.91K 0.01% 1059
2022
Q1
$840K Buy
85,021
+1
+0% +$10 0.01% 1191
2021
Q4
$844K Sell
85,020
-578
-0.7% -$5.72K ﹤0.01% 1280
2021
Q3
$851K Buy
85,598
+30,087
+54% +$297K 0.01% 1470
2021
Q2
$561K Buy
+55,511
New +$561K 0.01% 1652

HRT Financial's AKLI Position: Q3 2024 in Review

HRT Financial sold out of Akili Inc (AKLI) in Q3 2024, closing a stake of 49,833 shares — an estimated $21K sold.

HRT Financial first reported a position in AKLI in Q2 2021 and held it in 6 quarters. The position peaked at $851K in Q3 2021. 0 funds tracked by Wall St. Rank hold AKLI as of Q3 2024.

  • HRT Financial reported no remaining Akili Inc position as of Q3 2024 after selling out during the quarter.
  • HRT Financial sold 49,833 Akili Inc shares in Q3 2024, an estimated $21K.
  • HRT Financial first reported a position in Akili Inc in Q2 2021 and held it in 6 quarters.
  • HRT Financial's Akili Inc position peaked at $851K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Akili Inc as of Q3 2024.

Based on HRT Financial's 13F filing for Q3 2024, filed 12 Nov 2024.